Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Gut Microbiota-Immunity Axis in ALS: A Role in Deciphering Disease Heterogeneity?

29 Jun 2021

Abstract excerpt

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder with an unknown etiology and no effective treatment, and is characterized by large phenotypic heterogeneity, including variable sites, ages of symptom onset and rates of disease progression. Increasing data support the role of the microbiota-immunity axis in the pathogenesis of neurodegenerative diseases. In the present study, we compared the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to Gut microbiota and health
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34209688
DOI: 10.3390/biomedicines9070753

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Gut Microbiota-Immunity Axis in ALS: A Role in Deciphering Disease Heterogeneity?PMID 34209688Read ↗

Microbial Influences on Amyotrophic Lateral Sclerosis: The Gut-Brain Axis and Therapeutic Potential of Microbiota ModulationSemantic proximity Read ↗

Gut microbiota in ALS: possible role in pathogenesis?Semantic proximity Read ↗

The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patientsSemantic proximity Read ↗

Pathophysiological Mechanisms of the Microbiota-Gut-Brain Axis in Amyotrophic Lateral Sclerosis: Intestinal Permeability, Neuroinflammation, and Therapeutic Horizons for Non-Motor SymptomsSemantic proximity Read ↗

Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controlsSemantic proximity Read ↗

The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS)Semantic proximity Read ↗

Gut microbiome correlates with plasma lipids in amyotrophic lateral sclerosisSemantic proximity Read ↗

The human gut microbiota in people with amyotrophic lateral sclerosisSemantic proximity Read ↗

Host genetics and gut microbiota influence lipid metabolism and inflammation: potential implications for ALS pathophysiology in SOD1G93A miceSemantic proximity Read ↗

Temporal evolution of the microbiome, immune system, and epigenome with disease progression in ALS miceSemantic proximity Read ↗

Amyotrophic Lateral Sclerosis (ALS) Genetics and Microbiota: A Comprehensive Review.Semantic proximity Read ↗

The Impact of Microbiota on the Pathogenesis of Amyotrophic Lateral Sclerosis and the Possible Benefits of Polyphenols. An OverviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.